7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 
      
    		                                                               
      cash flows from operating activities:
    		                                                               
      net earnings
    		-6,632,000,000 -259,000,000 1,314,000,000 280,000,000 710,000,000 1,146,000,000 1,158,000,000 39,000,000 475,000,000 1,055,000,000 1,130,000,000 -219,000,000 740,000,000 -171,000,000 852,000,000 593,000,000 581,000,000 -535,000,000 697,000,000 -19,000,000 565,000,000 1,202,000,000 46,000,000 202,000,000 96,000,000 492,000,000 519,000,000 241,000,000 16,000,000 299,000,000 338,000,000 223,000,000 201,000,000 252,000,000 132,000,000 263,000,000 146,000,000 168,000,000 -16,000,000 111,000,000 94,000,000 88,000,000 64,000,000 104,376,000 79,151,000 48,126,000 32,347,000 54,882,000 48,914,000 39,011,000 22,911,000 4,639,000 295,000 -38,832,000 22,603,000 29,264,000 28,213,000 28,063,000 22,823,000 26,319,000 23,200,000 24,502,000 24,250,000 
      adjustments to reconcile net earnings to net cash from operating activities
    		                                                               
      depreciation and amortization
    		317,000,000 315,000,000 314,000,000 314,000,000 313,000,000 306,000,000 308,000,000 315,000,000 328,000,000 304,000,000 346,000,000 375,000,000 391,000,000 397,000,000 390,000,000 378,000,000 381,000,000 356,000,000 361,000,000 343,000,000 298,000,000 330,000,000 288,000,000 168,000,000 162,000,000 158,000,000 155,000,000 141,000,000 139,000,000 111,000,000 104,000,000 97,000,000 91,000,000 87,000,000 86,000,000 89,000,000 78,000,000 76,000,000 35,000,000 29,000,000 29,000,000 26,000,000 27,000,000 23,992,000 22,907,000 21,783,000 20,318,000 17,200,000 17,292,000 17,237,000 15,691,000 15,974,000 16,626,000 16,653,000 16,613,000 15,272,000 14,488,000 14,242,000 14,325,000 13,380,000 13,702,000 12,391,000 12,527,000 
      stock compensation expense
    		52,000,000 35,000,000 59,000,000 31,000,000 49,000,000 62,000,000 70,000,000 49,000,000 50,000,000 56,000,000 61,000,000 54,000,000 51,000,000 59,000,000 70,000,000 76,000,000 40,000,000 36,000,000 51,000,000 63,000,000 54,000,000 47,000,000 117,000,000 71,000,000 34,000,000 34,000,000 38,000,000 40,000,000 38,000,000 34,000,000 33,000,000 36,000,000 37,000,000 30,000,000 32,000,000 36,000,000 29,000,000 32,000,000 51,000,000 23,000,000 15,000,000 17,000,000 16,000,000 13,387,000 11,863,000 11,453,000 11,297,000 9,404,000 10,297,000 8,580,000 8,375,000 6,915,000 6,424,000 5,618,000 6,375,000 4,908,000 4,424,000 4,445,000 4,394,000 3,650,000 3,336,000 3,428,000 3,460,000 
      impairment
    		6,743,000,000   0 0 0 13,000,000 51,000,000 440,000,000 18,000,000 20,000,000 579,000,000 289,000,000   0    0 0 0 72,000,000                                         
      deferred income taxes
    		129,000,000 -89,000,000 -27,000,000 -1,000,000 -26,000,000 -64,000,000 104,000,000 -92,000,000 174,000,000 -1,000,000 -159,000,000 51,000,000 -265,000,000 -429,000,000 12,000,000 11,000,000 -67,000,000 -232,000,000 156,000,000 103,000,000 -171,000,000 -95,000,000 112,000,000 130,000,000 -65,000,000 -33,000,000 23,000,000 -26,000,000 -107,000,000 -26,000,000 30,000,000 -76,000,000 26,000,000 -7,000,000 -51,000,000 109,000,000 -4,000,000 4,000,000 -17,000,000 -3,000,000 -1,000,000 -7,000,000 -6,000,000 22,931,000 -53,673,000 -3,385,000 -7,873,000 -3,919,000 -9,089,000 9,729,000 986,000 4,880,000 -28,682,000 3,509,000 5,855,000 2,254,000 3,306,000 -2,829,000 -700,000 3,305,000 2,084,000 3,978,000 950,000 
      (gain) loss on divestitures
    		0 0 10,000,000 -17,000,000 0 -5,000,000 -98,000,000 20,000,000                                                        
      changes in assets and liabilities
    		                                                               
      premium and trade receivables
    		-1,537,000,000 883,000,000 -2,684,000,000 -1,596,000,000 -1,678,000,000 152,000,000 -1,211,000,000 -51,000,000 -2,010,000,000 1,619,000,000 -1,938,000,000 -353,000,000 14,000,000 1,811,000,000 -3,099,000,000 -730,000,000 -209,000,000 377,000,000 -1,891,000,000 1,588,000,000 -481,000,000 1,023,000,000 -2,182,000,000 -757,000,000 -553,000,000 896,000,000 -662,000,000 -477,000,000 -143,000,000 -377,000,000 -176,000,000                                 
      other assets
    		298,000,000 126,000,000 -669,000,000 -32,000,000 482,000,000 70,000,000 -474,000,000 108,000,000 222,000,000 -10,000,000 -315,000,000 -24,000,000 397,000,000 54,000,000 -299,000,000 25,000,000 334,000,000 -171,000,000 -287,000,000 -215,000,000 -17,000,000 105,000,000 97,000,000 -220,000,000 33,000,000 -67,000,000 20,000,000 -103,000,000 63,000,000 -49,000,000 51,000,000 -107,000,000 -104,000,000 -24,000,000 89,000,000     31,000,000 -10,000,000 -17,000,000 -13,000,000 43,625,000 -22,892,000 -14,308,000 -14,425,000 64,661,000 -27,206,000 -38,196,000 5,000 907,000 398,000 996,000 524,000 1,228,000 -352,000 -1,029,000 151,000 -1,038,000 -2,709,000 -218,000 1,937,000 
      medical claims liabilities
    		1,367,000,000 206,000,000 1,603,000,000 373,000,000 -178,000,000 65,000,000 108,000,000 860,000,000 262,000,000 -620,000,000 759,000,000 421,000,000 -113,000,000 322,000,000 1,767,000,000 141,000,000 1,336,000,000 -80,000,000 405,000,000 -446,000,000 1,417,000,000 -106,000,000 252,000,000 -513,000,000 533,000,000 10,000,000 548,000,000 -55,000,000 663,000,000 232,000,000 485,000,000 -47,000,000 163,000,000 -115,000,000 358,000,000 130,000,000 -173,000,000 -8,000,000 196,000,000 142,000,000 28,000,000 139,000,000 227,000,000 132,586,000 192,280,000 87,913,000 196,221,000 67,674,000 -7,730,000 -5,760,000 117,385,000 -14,254,000 122,996,000 150,281,000 100,769,000  15,792,000 11,254,000 13,430,000  -436,000 4,261,000 -33,129,000 
      unearned revenue
    		-26,000,000 -187,000,000 208,000,000 4,000,000 60,000,000 -84,000,000 -34,000,000 -1,640,000,000 -17,000,000 -24,000,000 1,919,000,000 -1,933,000,000 1,889,000,000 -6,000,000 81,000,000 60,000,000 -86,000,000 -131,000,000 48,000,000 -316,000,000 -85,000,000 -39,000,000 -88,000,000 1,000,000 128,000,000 -116,000,000 -22,000,000 98,000,000 -352,000,000 -115,000,000 317,000,000 -236,000,000 14,000,000 -79,000,000 320,000,000 -258,000,000 351,000,000 14,000,000 -64,000,000 77,000,000 -2,000,000 -51,000,000 -51,000,000 75,000,000 72,066,000 -52,728,000 34,662,000 -5,252,000 20,044,000 -15,646,000 3,578,000 -97,370,000 102,192,000 11,309,000 8,576,000 -43,899,000 -52,718,000 -22,571,000 10,106,000 64,408,000 47,242,000 -12,668,000 -73,282,000 
      accounts payable and accrued expenses
    		2,472,000,000 -354,000,000 563,000,000 -25,000,000 1,201,000,000 -293,000,000 -1,411,000,000 271,000,000 2,509,000,000 -930,000,000 1,548,000,000 -265,000,000 645,000,000 -916,000,000 957,000,000 148,000,000 -292,000,000 1,253,000,000 32,000,000 1,446,000,000 -2,170,000,000 605,000,000 704,000,000 131,000,000 64,000,000 -973,000,000 357,000,000 -568,000,000 900,000,000 -1,022,000,000 157,000,000 -152,000,000 462,000,000 -20,000,000 -237,000,000 303,000,000 107,000,000 -43,000,000 35,000,000 -170,000,000 43,000,000 108,000,000 58,000,000 78,872,000 267,000,000 69,647,000 90,481,000 102,872,000 50,328,000 21,257,000 -22,745,000 38,398,000 17,138,000 -16,184,000 -60,826,000 50,303,000 23,325,000 -61,007,000 26,268,000 40,572,000 362,000 -43,969,000 40,433,000 
      other long-term liabilities
    		-1,819,000,000 1,043,000,000 814,000,000 14,000,000 -1,922,000,000 825,000,000 1,013,000,000 273,000,000 -1,498,000,000 1,111,000,000 970,000,000 -21,000,000 -195,000,000 657,000,000 401,000,000 129,000,000 -197,000,000 738,000,000 423,000,000 415,000,000 -365,000,000 667,000,000 361,000,000 117,000,000 -801,000,000 522,000,000 347,000,000 59,000,000 -666,000,000 388,000,000 477,000,000 23,000,000 -736,000,000 322,000,000 459,000,000                             
      other operating activities
    		   50,000,000 2,000,000   0    1,000,000 0   -1,000,000    6,000,000 5,000,000 8,000,000 6,000,000 -11,000,000 -1,000,000 -6,000,000 -7,000,000 16,000,000 -3,000,000 -1,000,000 30,000,000   3,000,000 1,000,000 -77,000,000 94,000,000 4,000,000 -7,000,000 1,000,000 2,000,000 3,000,000 2,000,000 74,787,000 8,965,000 7,035,000 5,213,000 8,179,000 -1,508,000 1,572,000 4,078,000 1,819,000 -4,814,000 -3,844,000 -1,078,000 6,632,000 -27,000 2,823,000 732,000 694,000 -3,118,000 -83,000 1,934,000 
      net cash from operating activities
    		1,356,000,000 1,785,000,000 1,510,000,000 -587,000,000 -978,000,000 2,175,000,000 -456,000,000 217,000,000 1,021,000,000 2,546,000,000 4,269,000,000 -1,576,000,000 3,332,000,000 3,354,000,000 1,151,000,000 675,000,000 1,802,000,000 1,685,000,000 43,000,000 2,981,000,000 -952,000,000 3,714,000,000 -240,000,000 -651,000,000 -99,000,000 917,000,000 1,316,000,000 -634,000,000 548,000,000 -526,000,000 1,846,000,000 450,000,000 97,000,000 -306,000,000 1,248,000,000 1,596,000,000 480,000,000 -420,000,000 195,000,000 201,000,000 62,000,000 350,000,000 45,000,000 369,266,000 441,845,000 159,444,000 252,445,000 170,856,000 130,731,000 37,946,000 42,993,000 -28,591,000 317,182,000 22,196,000 -32,096,000 172,023,000 36,519,000 -40,837,000 93,991,000 194,625,000 72,563,000 -59,756,000 -38,500,000 
      cash flows from investing activities:
    		                                                               
      capital expenditures
    		-211,000,000 -208,000,000 -135,000,000 -154,000,000 -153,000,000 -186,000,000 -151,000,000 -223,000,000 -136,000,000 -215,000,000 -225,000,000 -233,000,000 -247,000,000 -282,000,000 -242,000,000 -248,000,000 -225,000,000 -250,000,000 -187,000,000 -206,000,000 -251,000,000 -235,000,000 -177,000,000 -200,000,000 -194,000,000 -160,000,000 -176,000,000 -186,000,000 -127,000,000 -144,000,000 -218,000,000 -121,000,000 -120,000,000 -98,000,000 -83,000,000 -95,000,000 -117,000,000 -49,000,000 -45,000,000 -49,000,000 -43,000,000 -31,000,000 -27,000,000 -34,472,000 -26,960,000 -23,452,000 -18,116,000 -21,452,000 -16,326,000 -19,403,000 -10,654,000 -11,543,000 -13,159,000 -42,462,000 -14,980,000 -16,062,000 -21,187,000 -16,019,000 -15,725,000 28,656,000 -28,358,000 -40,503,000 -23,099,000 
      free cash flows
    		1,145,000,000 1,577,000,000 1,375,000,000 -741,000,000 -1,131,000,000 1,989,000,000 -607,000,000 -6,000,000 885,000,000 2,331,000,000 4,044,000,000 -1,809,000,000 3,085,000,000 3,072,000,000 909,000,000 427,000,000 1,577,000,000 1,435,000,000 -144,000,000 2,775,000,000 -1,203,000,000 3,479,000,000 -417,000,000 -851,000,000 -293,000,000 757,000,000 1,140,000,000 -820,000,000 421,000,000 -670,000,000 1,628,000,000 329,000,000 -23,000,000 -404,000,000 1,165,000,000 1,501,000,000 363,000,000 -469,000,000 150,000,000 152,000,000 19,000,000 319,000,000 18,000,000 334,794,000 414,885,000 135,992,000 234,329,000 149,404,000 114,405,000 18,543,000 32,339,000 -40,134,000 304,023,000 -20,266,000 -47,076,000 155,961,000 15,332,000 -56,856,000 78,266,000 223,281,000 44,205,000 -100,259,000 -61,599,000 
      purchases of investments
    		-172,000,000 -1,963,000,000 -1,630,000,000 -1,413,000,000 -2,336,000,000 -2,117,000,000 -1,317,000,000 -1,893,000,000 -1,530,000,000 -1,580,000,000 -1,619,000,000 -1,618,000,000 -2,004,000,000 -1,414,000,000 -1,700,000,000 -2,147,000,000 -1,663,000,000 -1,937,000,000 -1,653,000,000 -4,491,000,000 -1,062,000,000 -449,000,000 -1,400,000,000 -501,000,000 -794,000,000 -700,000,000 -580,000,000 -1,155,000,000 -1,316,000,000 -610,000,000 -765,000,000 -984,000,000 -426,000,000 -700,000,000 -594,000,000 -922,000,000 -572,000,000 -744,000,000 -212,000,000 -244,000,000 -564,000,000 -206,000,000 -307,000,000 -276,526,000 -263,127,000 -307,974,000 -167,373,000 -124,637,000 -128,426,000 -179,459,000 -358,131,000 -193,729,000 -95,057,000 -151,689,000 -255,212,000  -97,906,000 -62,816,000 -40,423,000  -76,606,000 -159,189,000 -146,935,000 
      sales and maturities of investments
    		1,623,000,000 1,272,000,000 1,236,000,000 1,638,000,000 1,650,000,000 1,056,000,000 1,441,000,000 1,150,000,000 2,080,000,000 1,145,000,000 1,148,000,000 960,000,000 837,000,000 958,000,000 1,047,000,000 1,389,000,000 1,260,000,000 1,418,000,000 1,391,000,000 1,513,000,000 1,640,000,000 866,000,000 902,000,000 562,000,000 528,000,000 336,000,000 383,000,000 416,000,000 854,000,000 276,000,000 445,000,000 564,000,000 345,000,000 641,000,000 349,000,000 701,000,000 362,000,000 390,000,000 203,000,000 251,000,000 142,000,000 165,000,000 111,000,000 86,289,000 98,369,000 109,348,000 111,994,000 128,127,000 92,063,000 146,463,000 212,508,000 155,912,000 180,290,000 104,378,000 149,341,000 87,280,000 59,676,000 75,121,000 45,327,000 118,295,000 160,393,000 174,266,000 117,469,000 
      divestiture proceeds, net of divested cash
    		   31,000,000 0 80,000,000 879,000,000 17,000,000 21,000,000 226,000,000 443,000,000 1,115,000,000     0   0 0 10,000,000 456,000,000                                         
      net cash (used in) investing activities
    		1,240,000,000       -949,000,000 435,000,000 -424,000,000 -253,000,000                                                     
      cash flows from financing activities:
    		                                                               
      proceeds from long-term debt
    		0 0 750,000,000 950,000,000 0 0 350,000,000 165,000,000 889,000,000 994,000,000 287,000,000 3,000,000 26,000,000 231,000,000 100,000,000 20,000,000 6,849,000,000 81,000,000 2,317,000,000 2,420,000,000 57,000,000 88,000,000 2,542,000,000 12,265,000,000 6,839,000,000 4,599,000,000 1,018,000,000  334,000,000 3,131,000,000 2,015,000,000  360,000,000 250,000,000 560,000,000                             
      payments and repurchases of long-term debt
    		-1,000,000 -749,000,000 -958,000,000 -28,000,000 -29,000,000 -378,000,000 -187,000,000 -346,000,000 -648,000,000   -288,000,000                                                    
      common stock repurchases
    		0 -432,000,000 -41,000,000 -943,000,000 -1,227,000,000 -803,000,000 -151,000,000 -31,000,000 -774,000,000 -405,000,000 -423,000,000 -1,433,000,000 -1,243,000,000 -349,000,000 -71,000,000 -248,000,000 -16,000,000 -4,000,000 -29,000,000 -56,000,000 -9,000,000 -3,000,000 -558,000,000 -34,000,000 -4,000,000 -2,000,000 -35,000,000 -54,000,000 -4,000,000 -4,000,000 -9,000,000 -47,000,000 -3,000,000 -2,000,000 -13,000,000 -34,000,000 -2,000,000 -5,000,000 -22,000,000 -44,000,000 -2,000,000 -3,000,000 -4,000,000 -23,368,000 -763,000 -2,857,000 -2,012,000 -14,102,000 -4,572,000 -540,000 -565,000 -10,587,000 -363,000 -282,000 -1,509,000 -6,529,000 -251,000 -627,000 -402,000 -2,510,000 -146,000 -88,000 -480,000 
      proceeds from common stock issuances
    		11,000,000 8,000,000 10,000,000 9,000,000 12,000,000 11,000,000 14,000,000 12,000,000 11,000,000                                                       
      purchase of noncontrolling interest
    		       -1,000,000 -2,000,000 -27,000,000 -58,000,000                 -11,000,000 0   -33,000,000     0 0 -14,000,000                         
      other financing activities
    		-1,000,000 -1,000,000 -11,000,000 -1,000,000 -1,000,000 -1,000,000 -3,000,000    11,000,000 -84,000,000 25,000,000 6,000,000 26,000,000 16,000,000 15,000,000 9,000,000 15,000,000 12,000,000 13,000,000 15,000,000 7,000,000 4,000,000 3,000,000 7,000,000 2,000,000 11,000,000 -1,000,000 1,000,000 -2,000,000 3,000,000 -4,000,000 3,000,000 3,000,000 -15,000,000 -6,000,000 5,000,000 2,000,000                         
      net cash (used in) financing activities
    		-10,000,000        -524,000,000 -750,000,000 -183,000,000                                                     
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		   1,000,000 0 1,000,000 6,000,000                  2,000,000                                       
      net increase in cash, cash equivalents and restricted cash and cash equivalents
    		2,586,000,000 -288,000,000 731,000,000 -497,000,000 -3,062,000,000 -162,000,000 425,000,000         -420,000,000 2,439,000,000    -611,000,000    -664,000,000 541,000,000 1,001,000,000                                     
      cash and cash equivalents reclassified (to) from held for sale
    		                                                               
      cash, cash equivalents and restricted cash and cash equivalents, beginning of period
    		0 0 14,156,000,000 0 0 0 17,452,000,000                                                         
      cash, cash equivalents and restricted cash and cash equivalents, end of period
    		2,586,000,000 -288,000,000 14,887,000,000 -494,000,000 -3,065,000,000 -162,000,000 17,877,000,000                                                         
      supplemental disclosures of cash flow information:
    		                                                               
      interest paid
    		138,000,000 191,000,000 129,000,000 193,000,000 143,000,000 197,000,000 155,000,000 192,000,000 148,000,000 204,000,000 144,000,000 195,000,000 135,000,000 188,000,000 139,000,000 179,000,000 124,000,000 225,000,000 130,000,000 246,000,000 119,000,000 256,000,000 104,000,000 161,000,000 81,000,000 45,000,000 87,000,000 110,000,000 83,000,000 57,000,000 73,000,000 27,000,000 111,000,000 27,000,000 72,000,000 52,000,000 77,000,000 33,000,000 3,000,000 27,000,000 1,000,000 25,000,000 2,000,000 22,098,000 1,463,000 14,791,000 1,648,000 13,271,000 1,568,000 13,760,000 1,410,000 9,478,000 1,815,000 8,723,000 1,589,000 11,286,000 4,275,000 10,108,000 1,714,000 7,795,000 2,181,000 6,975,000 345,000 
      income taxes paid
    		36,000,000 497,000,000 7,000,000 181,000,000 211,000,000 597,000,000 13,000,000 124,000,000 167,000,000 581,000,000 11,000,000 774,000,000 37,000,000 400,000,000 11,000,000 201,000,000 71,000,000 386,000,000 20,000,000 271,000,000 845,000,000 72,000,000 3,000,000 101,000,000 130,000,000 375,000,000 6,000,000 108,000,000 145,000,000 194,000,000 1,000,000 138,000,000 153,000,000 203,000,000 2,000,000 162,000,000 172,000,000 189,000,000 33,000,000 99,000,000 84,000,000 121,000,000 24,000,000 69,717,000 57,165,000 88,853,000 21,265,000 43,760,000 19,227,000 19,489,000 2,205,000 8,876,000 1,607,000 11,880,000 20,514,000 448,000 9,885,000 30,544,000 9,567,000 9,531,000 16,467,000 19,668,000 8,272,000 
      the following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the consolidated balance sheets to the totals above:
    		                                                               
      cash and cash equivalents
    		2,545,000,000 -302,000,000 14,815,000,000 -514,000,000 -3,028,000,000 20,000,000 17,585,000,000 -997,000,000 1,020,000,000 1,317,000,000 15,853,000,000 -2,913,000,000 1,552,000,000 2,198,000,000 11,237,000,000 -305,000,000 2,405,000,000 1,391,000,000 9,627,000,000 -1,398,000,000 -600,000,000 3,490,000,000 9,308,000,000  -660,000,000 530,000,000 6,345,000,000                                     
      restricted cash and cash equivalents, included in restricted deposits
    		41,000,000 14,000,000 72,000,000 20,000,000 -37,000,000 -182,000,000 292,000,000 -1,000,000 -98,000,000 46,000,000 312,000,000 28,000,000 82,000,000 -116,000,000 262,000,000 -115,000,000 34,000,000 -500,000,000 677,000,000 11,000,000 -11,000,000 8,000,000 149,000,000  -4,000,000 11,000,000 6,000,000                                     
      total cash, cash equivalents and restricted cash and cash equivalents
    		2,586,000,000 -288,000,000 14,887,000,000  -3,065,000,000 -162,000,000 17,877,000,000                                                         
      other adjustments
    		 11,000,000 5,000,000 18,000,000 9,000,000 -9,000,000 -2,000,000 14,000,000 90,000,000 61,000,000 7,000,000 -195,000,000 2,000,000 140,000,000 22,000,000 -5,000,000 -20,000,000 12,000,000 2,000,000   -22,000,000 24,000,000                                         
      net cash from investing activities
    		  -529,000,000 102,000,000 -839,000,000 -1,167,000,000 852,000,000      3,000,000 -744,000,000 -2,401,000,000 -857,000,000 -1,022,000,000 -813,000,000 -607,000,000 -4,255,000,000 332,000,000 240,000,000 -3,272,000,000 -144,000,000 -459,000,000 -556,000,000 -373,000,000 -1,022,000,000 -2,310,000,000 -489,000,000 -764,000,000 -579,000,000 -200,000,000 -157,000,000 -329,000,000 -765,000,000 -313,000,000 -483,000,000 -836,000,000 -44,000,000 -470,000,000 -74,000,000 -225,000,000 -266,555,000 -191,868,000 -239,093,000 -150,484,000 -17,962,000 -48,630,000 -119,231,000 -156,277,000 -49,360,000 72,074,000 -89,773,000 -120,851,000 -47,925,000 -60,040,000 -9,133,000 -11,978,000 -174,618,000 50,055,000 -44,880,000 -41,164,000 
      net cash from financing activities
    		  -250,000,000 -13,000,000 -1,245,000,000 -1,171,000,000 23,000,000     -1,732,000,000 -1,481,000,000 -486,000,000 -498,000,000 -235,000,000 1,643,000,000 27,000,000 -73,000,000 -123,000,000 4,000,000 -460,000,000 839,000,000 6,704,000,000 -108,000,000 178,000,000 58,000,000 152,000,000 82,000,000 3,865,000,000 513,000,000 -79,000,000 -42,000,000 49,000,000 -10,000,000 119,000,000 104,000,000 177,000,000 2,317,000,000 -62,000,000 106,000,000 25,000,000 236,000,000 -75,099,000 74,687,000 67,654,000 130,758,000 143,898,000 -29,532,000 39,206,000 123,000 125,282,000 -14,529,000 56,473,000 12,247,000 -2,057,000 728,000 32,375,000 -24,134,000 16,493,000 9,448,000 20,147,000 26,001,000 
      (gain) loss on debt extinguishment
    		           1,000,000 -10,000,000 -13,000,000 -3,000,000                                                 
      (gain) on acquisition
    		           0                                                    
      loss on disposal of equipment
    		                                                               
      acquisitions, net of cash acquired
    		           -3,000,000 55,000,000 -8,000,000 -1,504,000,000 0 -394,000,000 18,000,000 -158,000,000 -1,049,000,000 0 48,000,000 -3,048,000,000 -5,000,000 1,000,000    -1,721,000,000 -11,000,000 -226,000,000                                 
      payments for debt extinguishment
    		           0 13,000,000 0 -27,000,000 0 -103,000,000 0 -54,000,000 -60,000,000 0 0 -21,000,000                                         
      equity issued in connection with acquisitions
    		                   0 0 0 11,526,000,000     0 0 183,000,000 324,000,000     0 0 0 3,105,000,000 0 -1,000,000 0 13,000,000                     
      total cash, cash equivalents, and restricted cash and cash equivalents
    		       -998,000,000 922,000,000 1,363,000,000 16,165,000,000 -2,885,000,000 1,634,000,000 2,082,000,000 11,499,000,000 -420,000,000 2,439,000,000 891,000,000 10,304,000,000 -1,387,000,000 -611,000,000 3,498,000,000 9,457,000,000  -664,000,000 541,000,000 6,351,000,000                                     
      other investing activities
    		              -2,000,000       0 -5,000,000           0 -1,000,000                             
      debt issuance costs
    		               0 -44,000,000 -1,000,000 -27,000,000 -26,000,000 -1,000,000 -1,000,000 -92,000,000 -19,000,000    0                                    
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		        26,000,000 -9,000,000 2,000,000 26,000,000 -28,000,000 -42,000,000 33,000,000 -3,000,000 16,000,000 -8,000,000 -16,000,000 10,000,000 5,000,000 4,000,000 -1,000,000                                         
      net increase in cash, cash equivalents, and restricted cash and cash equivalents
    		        958,000,000 1,363,000,000 3,835,000,000 -3,061,000,000                                                    
      cash and cash equivalents reclassified from (to) held for sale
    		                                                               
      cash, cash equivalents, and restricted cash and cash equivalents, beginning of period
    		        0 0 12,330,000,000 0 0 0 13,214,000,000 0 0 0 10,957,000,000 0 0 0 12,131,000,000 0 0 0 5,350,000,000 0 0 0 4,089,000,000                                 
      cash, cash equivalents, and restricted cash and cash equivalents, end of period
    		        922,000,000 1,363,000,000 16,165,000,000 -2,885,000,000 1,634,000,000 2,082,000,000 11,499,000,000 -420,000,000 2,439,000,000 891,000,000 10,304,000,000 -1,387,000,000 -611,000,000 3,498,000,000 9,457,000,000 5,903,000,000 -664,000,000 541,000,000 6,351,000,000 -1,504,000,000 -1,680,000,000 2,850,000,000 5,684,000,000                                 
      the following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the consolidated balance sheets to the totals above:
    		                                                               
      (gain) on divestiture
    		         -93,000,000 -79,000,000                                                     
      (gain) on divestitures
    		                                                               
      gain on acquisition
    		               0                                                
      gain on divestiture
    		                0   0 0 -11,000,000 -93,000,000                                         
      payments of long-term debt
    		             -374,000,000 -526,000,000 -23,000,000 -5,058,000,000 -58,000,000 -2,295,000,000 -2,413,000,000 -56,000,000 -559,000,000 -1,039,000,000 -5,510,000,000 -6,940,000,000 -4,426,000,000 -927,000,000  -221,000,000 -1,980,000,000 -1,491,000,000  -362,000,000 -202,000,000 -560,000,000                             
      net decrease in cash, cash equivalents and restricted cash and cash equivalents
    		              -1,715,000,000    -653,000,000                                             
      loss on debt extinguishment
    		               0 79,000,000 0 46,000,000 13,000,000 0 0 44,000,000                                         
      gain on divestitures
    		                                                               
      divestiture proceeds
    		                                                               
      proceeds from the issuance of common stock
    		                           0 -1,000,000                                   
      net increase in cash, cash equivalents, and restricted cash and equivalents
    		                                                               
      net increase
    		                      -2,674,000,000                                         
      goodwill and intangible impairment
    		                       0                                        
      contribution from noncontrolling interest
    		                                       9,000,000    593,000 0 0 5,407,000 2,204,000 1,944,000 3,718,000 202,000  50,000       0 0 0 306,000 
      debt extinguishment costs
    		                                                       0 0       
      investments in acquisitions, net of cash acquired
    		                                   -449,000,000 14,000,000 -80,000,000 -782,000,000 -2,000,000 -5,000,000 -2,000,000 -9,000,000 -41,846,000 -150,000 -17,015,000 -76,989,000 0 4,059,000        0    -5,374,000 -19,454,000 -2,019,000 
      proceeds from borrowings
    		                                   1,990,000,000 1,245,000,000 1,921,000,000 3,790,000,000 620,000,000 555,000,000 250,000,000 500,000,000 490,000,000 240,000,000 500,000,000 645,000,000 150,000,000 0   185,500,000 140,000,000   0 0 291,883,000 127,300,000 164,726,000 11,651,000 20,131,000 22,030,000 
      payment of long-term debt
    		                                            -171,684,000 -426,479,000 -519,413,000  -30,724,000 -9,342,000 -776,000 -40,812,000 -155,821,000 -20,806,000 -795,000 -808,000 -780,000 -262,118,000 -152,577,000 -98,261,000 -274,000 -57,000 -97,136,000 
      net increase in cash, cash equivalents and restricted cash
    		                           -1,504,000,000 -1,680,000,000 2,850,000,000 1,595,000,000                                 
      gain on contingent consideration
    		                                   -3,000,000 -1,000,000 0 -1,000,000                         
      goodwill and intangible adjustment
    		                                       10,000,000                        
      effect of exchange rate changes on cash and cash equivalents
    		                                   -2,000,000        -511,000                    
      net increase in cash and cash equivalents
    		                               -209,000,000 -144,000,000 -414,000,000 909,000,000 948,000,000 272,000,000 -726,000,000 1,676,000,000 95,000,000 -302,000,000 301,000,000 56,000,000 27,101,000 324,175,000 -11,995,000 232,719,000 296,792,000    47,331,000 374,727,000 -11,104,000 -140,700,000 122,041,000 -22,793,000 -17,595,000 57,879,000 36,500,000 132,066,000   
      cash and cash equivalents, beginning of period
    		                               0 0 0 3,930,000,000 0 0 0 1,760,000,000 0 0 0 1,610,000,000 -73,000 0 0 1,038,073,000 0 0 0 843,952,000 0 0 0 573,698,000 0 0 0 434,166,000 0 0 0 403,752,000 
      cash and cash equivalents, end of period
    		                               -209,000,000 -144,000,000 -414,000,000 4,839,000,000 948,000,000 272,000,000 -726,000,000 3,436,000,000 95,000,000 -302,000,000 301,000,000 1,666,000,000 27,028,000 324,175,000 -11,995,000 1,270,792,000 296,792,000 52,569,000 -42,079,000 730,791,000 47,331,000 374,727,000 -11,104,000 432,998,000 122,041,000 -22,793,000 -17,595,000 492,045,000 36,500,000 132,066,000 -84,489,000 350,089,000 
      premium and related receivables
    		                                -53,000,000 -755,000,000 59,000,000 980,000,000 215,000,000 -947,000,000 -174,000,000 0 -19,000,000 -7,000,000 -334,000,000 -219,968,000 -82,318,000 -41,507,000 -119,207,000 -84,390,000 12,643,000 -14,496,000 -56,734,000 22,856,000 93,331,000 -111,961,000 -120,784,000 2,000,000 2,840,000 -20,362,000 4,216,000 44,766,000 -10,407,000 -53,261,000 -4,457,000 
      other long term liabilities
    		                                   -217,000,000 -307,000,000 271,000,000 192,000,000 -50,000,000 -43,000,000 76,000,000 68,000,000                     
      payment of long term debt
    		                                   -1,819,000,000 -1,133,000,000 -1,736,000,000 -1,388,000,000 -673,000,000 -431,000,000 -226,000,000 -253,000,000                     
      other current assets
    		                                    -55,000,000 9,000,000 -35,000,000 7,000,000 -75,000,000 -25,000,000 -3,000,000 19,678,000 -53,504,000 25,415,000 3,411,000 -60,455,000 16,746,000 14,658,000 -50,537,000 -13,331,000 10,618,000 -23,382,000 -10,723,000 -5,145,000 -2,666,000 -2,365,000 -1,636,000 -308,000 -3,880,000 2,323,000 -1,375,000 
      debt issue costs
    		                                    0 -8,000,000 -51,000,000 0 0 0 -4,000,000 -525,000 -456,000   -2,000 0 -2,926,000 -661,000     0 -147,000 -2,990,000 -6,105,000     
      proceeds from asset sale
    		                                       0 0 0 7,000,000                     
      proceeds from exercise of stock options
    		                                       8,000,000 2,000,000 1,000,000 2,000,000 2,528,000 1,802,000 2,206,000 1,464,000 1,309,000 3,807,000 2,459,000 1,408,000 4,226,000 1,366,000 1,241,000 9,079,000 2,233,000 1,318,000 5,746,000 6,518,000 1,025,000 635,000 1,240,000 519,000 
      proceeds from stock offering
    		                                               0 -14,000           0 0 -23,000 104,557,000 
      excess tax benefits from stock compensation
    		                                       18,000,000 1,000,000 3,000,000 3,000,000 12,097,000 5,788,000 803,000 312,000 5,240,000 27,000 598,000 515,000 4,947,000 239,000 338,000 5,472,000 2,803,000 263,000 237,000 1,132,000 539,000 129,000 199,000 96,000 
      payment of contingent consideration obligation
    		                                       0 -21,000,000 0 -8,000,000                     
      gain on settlement of contingent consideration
    		                                        -27,000,000 0 -10,000,000                     
      health insurer fee paid
    		                                                               
      impairment loss
    		                                                   0 0           
      gain on sale of investment in convertible note
    		                                                   0            
      equity issued in connection with acquisition
    		                                            58,041,000 0 132,371,000 0 -13,000               
      net decrease in cash and cash equivalents
    		                                                 -42,079,000 -113,161,000            -53,663,000 
      gain on sale of investments
    		                                                   -24,000    -74,000 -106,000 11,000 -118,000     
      gain on sale of uhp
    		                                                               
      proceeds from asset sales
    		                                                           0 0 0 13,420,000 
      contribution from (to) noncontrolling interest
    		                                                               
      supplemental disclosure of non-cash investing and financing activities:
    		                                                               
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                                               
      (gain) on sale of uhp
    		                                                           0 0 0 -8,201,000 
      impairment loss on casenet, llc
    		                                                               
      changes in assets and liabilities:
    		                                                               
      medical claims liability
    		                                                               
      capital expenditures of centene center llc
    		                                                       -708,000 -623,000 -2,227,000 -1,157,000     
      purchase of investments
    		                                                               
      investments in acquisitions, net of cash acquired, and investment in equity method investee
    		                                                               
      distributions from (to) noncontrolling interest
    		                                                               
      impairment of investment
    		                                                               
      contributions from (distributions to) noncontrolling interest
    		                                                        325,000       
      distributions to noncontrolling interest
    		                                                             -1,255,000 -3,585,000 
      (gain) loss on sale of investments
    		                                                           -6,000 -2,344,000 -440,000 -3,547,000 
      distributions (to) from noncontrolling interest
    		                                                           0    
      gain on sale of firstguard missouri
    		                                                               
      property acquired under capital lease obligation
    		                                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.